ArticleJournal of the American Heart Association2026

Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.

Sara Vázquez-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.